Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001103780-16-000091)

Filing Details

Accession Number:: 0001103780-16-000091
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-08-22 18:49:53
Reporting Period:: 2010-01-20

Filing Date:: 2016-08-22
Accepted Time:: 2016-08-22 18:49:53
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1348362	Lexaria Bioscience Corp.	LXRP	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1103780	Christopher Bunka	1924 Birkdale Ave Kelowna A1 V1P1R7	Ceo	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Acquisiton	2016-08-19	10,500	$0.13	7,171,042	No	4	P	Direct
Common Shares	Acquisiton	2016-08-22	9,300	$0.13	7,180,342	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Shares	5,421,844	Indirect	Private holding company
Common Shares	7,160,542	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Shares	Stock Options	$0.10	2014-12-23	2019-12-23	550,000	550,000	Direct
Common Shares	Stock Options	$0.09	2013-06-18	2018-06-18	247,500	797,500	Direct
Common Shares	Warrants	$0.23	2015-05-15	2017-05-15	187,000	187,000	Indirect
Common Shares	Warrants	$0.14	2016-08-11	2018-08-11	450,000	637,000	Indirect

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2019-12-23	550,000	550,000	Direct
2018-06-18	247,500	797,500	Direct
2017-05-15	187,000	187,000	Indirect
2018-08-11	450,000	637,000	Indirect